MedPath
HSA Product

GRALISE EXTENDED RELEASE TABLETS 300 MG

Product approved by Health Sciences Authority (SG)

Basic Information

GRALISE EXTENDED RELEASE TABLETS 300 MG

TABLET, EXTENDED RELEASE

Regulatory Information

SIN17166P

January 16, 2025

Prescription Only

Therapeutic

ORAL

May 23, 2025

June 3, 2025

Company Information

LOTUS INTERNATIONAL PTE. LTD.

Active Ingredients

Gabapentin

Strength: 300.00 mg

© Copyright 2025. All Rights Reserved by MedPath